Advances in graft-versus-host disease biology and therapy.

Nature Reviews. Immunology
Bruce R BlazarMehrdad Abedi

Abstract

Allogeneic haematopoietic stem cell transplantation is used to treat a variety of disorders, but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past decade has brought impressive advances in our understanding of the role of stimulatory and suppressive elements of the adaptive and innate immune systems from both the donor and the host in GVHD pathogenesis. New insights from basic immunology, preclinical models and clinical studies have led to novel approaches for prevention and treatment. This Review highlights the recent advances in understanding the pathophysiology of GVHD and its treatment, with a focus on manipulations of the immune system that are amenable to clinical application.

References

May 10, 1979·The New England Journal of Medicine·P L WeidenR Storb
Feb 1, 1990·Nature·J L Goldstein, M S Brown
Feb 1, 1995·Trends in Genetics : TIG·J N Ihle, I M Kerr
Jun 3, 1999·The New England Journal of Medicine·E C GuinanJ G Gribben
Oct 26, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·M SykesB R Blazar
May 3, 2000·The Journal of Clinical Investigation·B NikolicM Sykes
Jun 4, 2002·Nature Medicine·Takanori TeshimaJames L M Ferrara
Aug 7, 2002·The Journal of Experimental Medicine·José L CohenBenoît L Salomon
Jul 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bruce R BlazarPatricia A Taylor
Oct 24, 1962·Annals of the New York Academy of Sciences·D W BARNESH S MICKLEM
Oct 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wim JanssensJean-Marie R Saint-Remy
Jan 22, 2004·Hematological Oncology·Pavan Reddy
Mar 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pavan ReddyJames L M Ferrara
Mar 24, 2004·Seminars in Immunology·Ciriaco A Piccirillo, Ethan M Shevach
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kai SunWilliam J Murphy
Jun 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ulrich A DuffnerTakanori Teshima
Aug 3, 2004·Nature Medicine·Catherine C MatteWarren D Shlomchik
Oct 21, 2004·Blood·Sudeepta Aggarwal, Mark F Pittenger
Feb 11, 2005·Blood·Christian A WysockiJonathan S Serody
Jun 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Birgit KnoechelAbul K Abbas

❮ Previous
Next ❯

Citations

Sep 8, 2012·Current Allergy and Asthma Reports·Sheryl MascarenhasStacy P Ardoin
Oct 13, 2012·Cancer Gene Therapy·M K Brenner
Aug 25, 2012·Current Opinion in Hematology·Giacomo OliveiraChiara Bonini
Jun 7, 2013·Science Translational Medicine·Gerald P MorrisPaul M Allen
Dec 18, 2013·Science Translational Medicine·Victor D FedorovMichel Sadelain
Oct 24, 2012·Bone Marrow Research·Aleksandra Klimczak, Andrzej Lange
May 17, 2013·The Journal of Clinical Investigation·Arnab GhoshMarcel R M van den Brink
Nov 13, 2013·The Journal of Clinical Investigation·Yaping SunPavan Reddy
Aug 21, 2013·Medicine and Science in Sports and Exercise·Carmen Fiuza-LucesAlejandro Lucia
Sep 17, 2013·Bone Marrow Transplantation·J R RogosheskeC G Brunstein
Sep 10, 2013·Brain, Behavior, and Immunity·Mark L Laudenslager
Sep 7, 2013·Stem Cells and Development·Dominique J BarbeauKenichi Tamama
Jan 7, 2014·Current Hematologic Malignancy Reports·Frédéric BaronYves Beguin
Aug 6, 2014·Nature Biotechnology·Johannes L ZakrzewskiJeffrey A Hubbell
Apr 5, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Jianing FuXue-Zhong Yu
Apr 12, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kai ZhaoKailin Xu
Sep 10, 2014·Expert Review of Clinical Immunology·Perla Filippini, Sergio Rutella
Jan 9, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sumithira VasuSteven M Devine
Jan 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·David A KnorrMichael R Verneris
Dec 5, 2015·Annals of Hematology·Holger BuddeTobias J Legler
Nov 10, 2015·Bone Marrow Transplantation·S G Holtan, M L MacMillan
Feb 24, 2016·Human Immunology·Petya Apostolova, Robert Zeiser
Mar 25, 2014·Dental Clinics of North America·Michal Kuten-ShorrerNathaniel S Treister
Dec 8, 2015·The FEBS Journal·Jessica L StolfiWilliam J Murphy
Apr 2, 2013·Gastrointestinal Endoscopy Clinics of North America·Zaree Babakhanian, John A Donovan
Dec 12, 2012·Trends in Immunology·Fadi IssaKathryn J Wood
Oct 17, 2012·The Journal of Evidence-based Dental Practice·Jacqueline W MaysNiki M Moutsopoulos
Jan 14, 2016·Immunogenetics·Trishna ManandharChristina Bade-Doeding
Jun 19, 2012·Journal of Autoimmunity·Robert A Eisenberg, Charles S Via
Jul 19, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Dmitry BalashovAlexei Maschan
Dec 10, 2015·Nature·Konrad Gronke, Andreas Diefenbach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.